Home/ Supplements/ Omega 3/ CitraNatal Assure 300 mg DHA Soft Gel

CitraNatal Assure 300 mg DHA Soft Gel

product on market Softgel Capsule Mission Pharmacal CitraNatal Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Docosahexaenoic acid and eicosapentaenoic acid are omega-3 fatty acids that support fetal brain and retinal development. There is strong research evidence supporting the role of DHA in neonatal neurological health. These ingredients are generally recognized as safe for prenatal use.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for CitraNatal Assure 300 mg DHA Soft Gel
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
Amino acid/Protein
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

Gelatin Sunflower Oil Glycerin Caramel color Sunflower Lecithin Rosemary extract Tocopherols Ascorbyl Palmitate
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

Dosage and administartion: One tablet and one soft gel daily or as directed by a physician.

Warnings & Precautions

Warning: Ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including an increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis.

Caution: Exercise caution to ensure that the prescribed dosage of DHA does not exceed 1 gram (1000 mg) per day.

To report a serious adverse event or obtain product information, call (800) 531-3333.

Formulation Notes

Description: CitraNatal Assure is a prescription prenatal/postnatal multi vitamin/mineral tablet with Ferr-Ease, a patented dual-iron delivery comprising both a quick release and slow release iron, and a soft gel of DHA, an essential fatty acid. The prenatal vitamin is a white, coated, oval multi-vitamin/mineral tablet. The tablet is debossed “0891” on one side and is blank on the other. The essential fatty acid DHA soft gel is caramel colored and contains a light yellow to orange semi-solid mixture.

Indications: CitraNatal Assure is a multi-vitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.

Additional Information

Storage: Store at 20(0)C to 25(0)C (68(0)F to 77(0)F), excursions permitted between 15(0)C and 30(0)C (between 59(0)F and 86(0)F). Brief exposure to temperatures up to 40(0)C (104(0)F) may be tolerated provided the mean kinetic temperature does not exceed 25(0)C (77(0)F); however, such exposure should be minimized.

How supplied: Six child-resistant blister packs of 5 tablets and 5 soft gels each - NDC 0178-0891-30

Please consult your health care provider with any dietary concerns.

Metadata

Product Details

DSLD Entry Date2019-09-24
Product TypeAmino acid/Protein
FormSoftgel Capsule
DSLD ID206922
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.